EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pentahydroxyflavone and Metformin Mitigate Diabetes‐Induced Hepatic Dysfunction in Gamma‐Irradiated Rats Through the AMPK‐SREBP‐1c‐SCD1 Pathway

Hanaa F B Gaber, Fatma S M Moawed iD, Mohamed K Mahfouz, Esraa S A Ahmed iD, Omayma A R Abo-Zaid iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Hanaa F B Gaber und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Biology Department, Faculty of Veterinary Medicine, Benha University, Al-Qalyubia, Egypt. Hauptthemen laut MEDLINE: Metformin, AMP-Activated Protein Kinases, Diabetes Mellitus, Experimental, Sterol Regulatory Element Binding Protein 1. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) is a common complication among cancer patients, potentially worsening the adverse effects of radiation therapy. This study aimed to evaluate whether pentahydroxy flavone (PHF) and Metformin (MET) could mitigate liver damage associated with streptozotocin (STZ)‐induced diabetes in rats exposed to gamma irradiation (IR). Diabetes was induced in rats by a single dose of STZ (35 mg/kg) and exposure to a cumulative IR dose (4 Gy). Over one month, each treatment group received either PHF (50 mg/kg) or MET (200 mg/kg). Combined treatment with PHF and MET improved lipid profiles, reduced insulin resistance, coupled with diminishing hepatic inflammation (NLRC4) and oxidative stress. Furthermore, co‐administration of PHF and MET modulated the AMPK/ SREBP1c/ SCD1‐related signaling, ameliorating hepatic steatosis and fibrosis. These findings suggest that PHF combined with MET's could serve as an adjuvant therapy alongside MET to protect against liver damage caused by diabetes and gamma radiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminAMP-Activated Protein KinasesDiabetes Mellitus, ExperimentalSterol Regulatory Element Binding Protein 1LiverOxidative StressGamma RaysAnimalsRatsRats, WistarFlavonoids

Stichwörter der Autor:innen

AMPK/ SREBP1c/ SCD1diabetes mellitusgamma irradiationmetforminpentahydroxy flavone

Substanzen

MetforminpeflavitAMP-Activated Protein KinasesSterol Regulatory Element Binding Protein 1Flavonoids

Autor:innen und Institutionen

  • Biochemistry and Molecular Biology Department, Faculty of Veterinary Medicine, Benha University, Al-Qalyubia, Egypt.
  • Health Radiation Research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
  • Radiation Biology Research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.

ORCID-Profile: Fatma S M Moawed, Esraa S A Ahmed, Omayma A R Abo-Zaid

Zitieren

APA

Gaber, H. F. B., Moawed, F. S. M., Mahfouz, M. K., Ahmed, E. S. A., & Abo-Zaid, O. A. R. (2026). Pentahydroxyflavone and Metformin Mitigate Diabetes‐Induced Hepatic Dysfunction in Gamma‐Irradiated Rats Through the AMPK‐SREBP‐1c‐SCD1 Pathway. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71801

Vancouver

Gaber HFB, Moawed FSM, Mahfouz MK, Ahmed ESA, Abo-Zaid OAR. Pentahydroxyflavone and Metformin Mitigate Diabetes‐Induced Hepatic Dysfunction in Gamma‐Irradiated Rats Through the AMPK‐SREBP‐1c‐SCD1 Pathway. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71801

BibTeX
@article{Gaber2026,
  author = {Gaber, Hanaa F B and Moawed, Fatma S M and Mahfouz, Mohamed K and Ahmed, Esraa S A and Abo-Zaid, Omayma A R},
  title = {Pentahydroxyflavone and Metformin Mitigate Diabetes‐Induced Hepatic Dysfunction in Gamma‐Irradiated Rats Through the AMPK‐SREBP‐1c‐SCD1 Pathway},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71801}
}
Kostenlos starten →